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The number of male deaths from pleural cancer in France, Germany and Italy increased from about 8750 in 1990–1994 to 9550 in
1995–1999, suggesting that mesothelioma deaths in males may be levelling off in most of Western Europe.
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Mortality from pleural mesothelioma is essentially a function of
past exposure to asbestos, which is considered to be an early-stage
carcinogen for mesothelioma (Peto et al, 1982). We applied a log-
linear age, period and cohort model to pleural cancer mortality
data to project the probable future trends in mesothelioma in
Europe (La Vecchia et al, 2000). This model indicated a peak in the
epidemic towards the end of the second decade of the current
century (2015–2019) in most major Western European countries,
and we estimated that about 250000 male deaths from pleural
cancer in the whole of Western Europe were in the period 1995–
2029 (Peto et al, 1999).
However, a recent report from Sweden found that pleural
mesothelioma incidence was levelling off in that country.
Considering the timing and effect of the introduction of a ban
on asbestos use, and the mesothelioma lag time following the
exposure to asbestos, it was hypothesised that incidence peaks in
other Western European countries might be anticipated between
2003 and 2013 (Hemminki and Li, 2003), slightly earlier than we
had predicted. The authors stressed that their data should be
considered cautiously, since the latency time from asbestos
exposure to disease occurrence has been estimated as longer than
30 years (Bianchi et al, 1997), while asbestos imports to Sweden
decreased markedly only in 1976 (Hemminki and Li, 2003).
Similarly, a cohort analysis of Norwegian data showed a levelling
of rates for men born after 1935 (Ulvestad et al, 2003), while an
analysis of pleural mesothelioma incidence trends revealed a
deceleration of the increase in some European countries (Mon-
tanaro et al, 2003).
Mortality data for the period 1995–1999, now available for most
major European countries (WHO Mortality Database, 2003), have
allowed us to compare observed and previously predicted deaths
to assess the reliability of the age-cohort model previously used
(Peto et al, 1999).
MATERIALS AND METHODS
Methods for predicting the number of male deaths from
mesothelioma have been reported elsewhere (Peto et al, 1999).
Briefly, the age and birth cohort effects were estimated by fitting a
log-linear Poisson model to the age-specific death rates, computed
using data from the World Health Organisation (WHO), for each
5-year calendar period from 1970–1974 to 1985–1989.
From this WHO database, updated at January 2003, we have
extracted, for Germany, France and Italy, the official number of
male deaths from pleural cancer for the period 1990–1999. Pleural
cancer was coded by two revisions of the International Classifica-
tion of Diseases (ICDs) (163.0 under ICD-8, WHO, 1967 and 163
under ICD-9, WHO, 1977). We have excluded Switzerland and the
Netherlands from this analysis, since these countries adopted, in
1995 and 1996 respectively, the Tenth Revision of the ICD that has
introduced a specific code – C45 – for mesothelioma (WHO, 1992).
Consequently, these data are not comparable with previous ones.
Since Germany adopted ICD-10 in 1998, we considered mortality
data for 1990–1994 and for 1997 only, that is, the central year of
the period 1995–1999, instead of 1995–1997 to avoid any potential
unbalancing upon the first half of the period. In any case, the
number of male pleural mesothelioma deaths in Germany reported
for 1995 (632 deaths) and 1996 (625 deaths) were closely
comparable to 1997 (632 deaths).
Important changes occurred at this time in death registrations in
Britain. In England and Wales, systematic medical enquiries to
clarify ambiguous causes of death were stopped in 1993 (Office for
National Statistics, 1996). Also, there were changes in the
automatic cause coding. Consequently, British data are difficult
to interpret and are not included in the present analysis.
To compute age-standardised mortality rates (ASMR), we used
the direct method based on 5-year age groups and adjusted to the
world standard population.
RESULTS
For the period 1995–1999, the observed male deaths for all three
countries considered were lower than predicted (Table 1).
Observed numbers were 2.3% lower than predicted for Germany,
Received 15 September 2003; revised 10 December 2003; accepted 12
December 2003
*Correspondence: Dr C Pelucchi; E-mail: pelucchi@marionegri.it
British Journal of Cancer (2004) 90, 1022–1024
& 2004 Cancer Research UK All rights reserved 0007– 0920/04 $25.00
www.bjcancer.com
E
p
i
d
e
m
i
o
l
o
g
y6.4% for Italy and 11.4% for France. For all countries, the
difference between the observed and predicted values was largest
in the youngest age group and smallest in the oldest.
The number of male pleural cancer deaths was similar in
Germany in 1997 as in 1990–1994. The observed values were lower
in 1995–1999 than in 1990–1994 in all countries at ages 40–54
years. In contrast, the observed number of deaths were all
higher in 1995–1999 in the 65–84 years age group. The
highest age-standardised mortality rate was reported for France
(1.54), followed by Italy (1.31) and Germany (1.05). In 1997, for
the first time since 1970–1974, the increasing trend in the
age-standardised male death rates reversed in Germany.
The Italian age-standardised death rate increased from 1.14 in
1985–1989 to 1.30 in 1990–1994, and then remained stable. France
showed the highest mortality rate, still increasing in 1995–1999
(þ8% compared with 1990–1994, þ126% compared with
1970–1974).
DISCUSSION
The total number of male deaths from pleural mesothelioma in
France, Germany and Italy has continued to increase during the
last decade of the 20th century, growing from approximately 7550
in 1985–1989 to 8750 in 1990–1994, and 9550 in 1995–1999.
However, for the latest period, all the observed values were lower
than predicted (Peto et al, 1999). This, together with the
stabilisation of ASMRs and the consistent decrease in mortality
at younger ages, supports the hypothesis that the rising trend in
deaths from mesothelioma in men should level off in the near
future in the above three countries as in Sweden (Hemminki and
Li, 2003).
It appears therefore that our models have overestimated the
number of mesothelioma deaths in men. For this, there are several
possible explanation. First, the data for the more recent cohorts
and those potentially involved in the first decrease of rates were
based on only a few observations (the 1945 birth cohort was based
on two rates) and on few deaths, so that there was a wide random
variation. Further, we assumed that the 1950 birth cohort
experienced the same rates as the 1945 cohort (which had the
highest rates), and that the 1955 birth cohort would have had 50%
lower rates (Peto et al, 1999). But apparently, the rates in the 1945
birth cohort were at the start of a decreasing trend, although it is
unlikely that this by itself can explain the overestimation since the
observed values were also generally lower than those predicted for
the older age groups.
Thus, to explain the development of the mesothelioma epidemic,
other factors need to be invoked, such as the type of asbestos
mainly used in different countries over time (Hodgson and
Darnton, 2000), duration of exposure and years since last exposure
(Hauptmann et al, 2002). It does, however, appear that the number
of asbestos-related mesothelioma deaths during 1995–2029 in
Europe is likely to be lower than the 250000 previously estimated
on data available up to 1994.
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